首页> 外文会议>International symposium on ceramics in medicine >The clinical outcome of bioactive-glass coated hip prostheses
【24h】

The clinical outcome of bioactive-glass coated hip prostheses

机译:生物活性玻璃涂层髋关节假体的临床结果

获取原文

摘要

A bioactive glass, previously described in literature, was clinically tested as a coating for hip prostheses. The glass was designed to be degradable in-vivo. Early implants in humans have been performed in 1991, giving 8 years as the longest follow-up. Authors investigated the clinical performance of the cementless bioactive-glass coated stem versus a cemented un-coated one; they matched two groups who had equal: a)-stem design; b)-surgical technique; c)-sex distribution. Fifty-two implants of a bioactive-glass coated hip stems were studied. They showed a good clinical response and a decrease in early-6-months thigh pain. Only two loosening have been recorded up to now. No significative differences have been observed between cementless coated stems and cemented un-coated stems; this fact stresses the point that surgical technique and stem design are probably more important than materials alone for the good outcome of hip prostheses.
机译:在文献中描述的生物活性玻璃,在临床上测试作为髋关节假体的涂层。玻璃设计成可降解的体内。人类早期植入物于1991年进行,使8年成为最长的随访。作者研究了软泥生物活性玻璃涂层茎的临床表现,与粘合的未涂层液体;他们匹配两组有相等的群体:a) - 策略设计; b) - 技术; c)-sex分布。研究了生物活性玻璃涂层髋肽的52个植入物。他们表现出良好的临床反应和早期6个月大腿疼痛的减少。现在只记录了两个松动。无固态涂层茎和胶水未涂层茎之间没有观察到具有重要意义;这一事实强调了手术技术和茎设计可能比单独的材料更重要,以获得髋关节假体的良好结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号